HomeProductsBuilding BlocksOrganometallic ReagentsOrganoboronTalabostat
Chemical structure of CAS 149682-77-9

Talabostat

CAS No.149682-77-9
MDL No.N/A
MFC9H19BN2O3
MW214.07
InChI KeyFKCMADOPPWWGNZ-YUMQZZPRSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.149682-77-9
Product NameTalabostat
Heavy Atom Count15Rotatable Bond Count3
Atom Stereo Count2Bond Stereo Count0
HBA4HBD3
TPSA86.790 ŲCharge0
Exact Mass214.14887Complexity235.40
pKa7.130XLogP-1.027

Related Articles

Studies related to this compound and its mechanism of action

Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer.

Clinical oncology (Royal College of Radiologists (Great Britain)) • Vol. 21, Issue 6 • 2009
PMID: 19501491DOI: 10.1016/j.clon.2009.04.007

Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease.

British journal of haematology • Vol. 145, Issue 6 • 2009
PMID: 19388929PMC: PMC2748971DOI: 10.1111/j.1365-2141.2009.07696.x

Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety.

Journal of medicinal chemistry • Vol. 51, Issue 19 • 2008
PMID: 18783201DOI: 10.1021/jm800390n

HIV-1 Env vaccine comprised of electroporated DNA and protein co-administered with Talabostat.

Biochemical and biophysical research communications • Vol. 370, Issue 1 • 2008
PMID: 18329382DOI: 10.1016/j.bbrc.2008.02.145

Documentation